As of Nov 25
| +0.03 / +2.65%|
The 1 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 3.29, with a high estimate of 3.29 and a low estimate of 3.29. The median estimate represents a +183.63% increase from the last price of 1.16.
The current consensus among 1 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.